1000 mosaic embryos and more: status update on PGT-A intermediate copy number

Review of the Viotti et al 2021 F&S paper describing outcomes of 1000 mosaic embryos transferred.
Discussion about controversies related to mosaicism reporting
Discussion about the impact that mosaicism reporting has on patients/downstream effects
Discussion about patient satisfaction/dissatisfaction with genetic counseling about mosaicism and impact of social media
Review of the updated PGDIS guidelines if publicly available by time of the webinar

Пікірлер: 3

  • @MandiSmash
    @MandiSmash2 жыл бұрын

    Thanks so much for this talk, it was wonderfully presented. On a side note, I wish insurance covered pgt-a testing. If they did, it would add a whole lot more data to these studies.

  • @juliearaujo1
    @juliearaujo1 Жыл бұрын

    what a great talk!

  • @toyaewing9675
    @toyaewing96752 жыл бұрын

    When stating the clinical impact of mosaicism in chromosomes 13, 18, 21 and X as chromosomes of interest, on the graph to the right, there was no data on X to show LBR and was excluded from the total. Was there any reason for that? Does mosaicism in sex chromosomes or specifically X, have a decreased LBR? Does Mosaicism in the XX/XY chromosomes have an increased risk for the diagnosis presenting in the live birth of the embryo? Awesome presentation with very valuable information!